NEW ALBANY, Ind., April 20, 2021 – RxLightning, a healthcare technology company that simplifies and automates the complex specialty medication enrollment process through a single comprehensive, user-friendly platform, today announced the addition of Elizabeth Johnson for the new role of Director of Product Management. Johnson is a Licensed Practical Nurse (LPN) and co-founder of the National Association of Medication Access & Patient Advocacy (NAMAPA), a non-profit that focuses on empowering healthcare advocates by providing a collaborative community focused on resources to navigate medication access and support.
“Elizabeth brings such great front-line experience and insight to our team, and we’re excited to be able to apply, not only her knowledge, but also her passion and her energy to our mission of getting patients the therapies they need faster by simplifying specialty drug enrollment,” said RxLightning founder and CEO Julia Regan. “We’re dedicated to growing RxLightning and getting more providers, pharmacies and manufacturers on board, particularly among specialty practices who spend an unnerving amount of time navigating the specialty enrollment process for their patients.”
Johnson began her career in allergy and immunology and became dedicated to solving the challenges of specialty medication access. Prior to RxLightning, Johnson served as the Lead Biologics Coordinator for Allergy Partners PLLC, the largest single specialty practice in the United States. She holds the Certified Professional Coder (CPC) certification and Prior Authorization Certified Specialist (PACS), exemplifying her knowledge of some of the most integral parts of the revenue cycle. Combining this knowledge with her love of training, Johnson has been able to successfully and consistently educate physician practices on various methods of acquisition for injectable and infused biologics and biosimilar medications.
“I’ve seen first-hand how quickly, dramatically and almost effortlessly RxLightning’s solution changes the game for providers and patients alike, and I’m honored to join the team,” Johnson said. “I’m particularly excited about being able to have an impact beyond a single specialty practice and help scale and grow and bring our solution to every corner of the country.”
The specialty medication market is the fastest-growing segment of the pharmaceutical industry, and RxLightning is the first to create a comprehensive, all-inclusive technology that replaces the existing archaic manual process and ultimately expedites patient access to critical therapies. The company recently announced its technology would be available to providers at no cost.
Founded in New Albany, Indiana in 2020, RxLightning digitizes, automates and streamlines the historically complicated manual enrollment process of starting a patient on specialty medications. Specialty medications are expected to account for 70% of new medication launches through 2023. With RxLightning, healthcare providers can quickly and easily complete the enrollment process for every specialty medication in every therapeutic area, helping reduce paperwork, streamline communication, and accelerate the speed of therapy for patients. Learn more at rxlightning.com.